← Back to Search

Procedure

HIFU for Prostate Cancer (STAR Trial)

N/A
Waitlist Available
Research Sponsored by SonaCare Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post treatment
Awards & highlights

STAR Trial Summary

This trial is testing a new treatment for prostate cancer that has come back after previous radiation therapy.

Eligible Conditions
  • Prostate Cancer

STAR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
absence of biochemical failure, defined as achieving a PSA nadir of ≤ 0.5 ng/mL within 12 months of treatment
Secondary outcome measures
negative prostate biopsy at the 12 month time point

STAR Trial Design

1Treatment groups
Experimental Treatment
Group I: HIFUExperimental Treatment1 Intervention
High Intensity Focused Ultrasound
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High Intensity Focused Ultrasound
2006
Completed Phase 2
~90

Find a Location

Who is running the clinical trial?

SonaCare MedicalLead Sponsor
6 Previous Clinical Trials
560 Total Patients Enrolled
3 Trials studying Prostate Cancer
486 Patients Enrolled for Prostate Cancer
Mark Carol, MDStudy DirectorSonaCare Medical, LLC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)
2008. "A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00772317.
All > Prostate > Recurrent Prostate Cancer
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top